Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) CEO Sells $592,959.60 in Stock
otakuyassine3@gmail.com Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Get Free Report) CEO Richard Scott Struthers sold 17,338 shares...
Pharmaceuticals
Q1 EPS Estimate for Jazz Pharmaceuticals Boosted by Analyst
Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) – Research analysts at Zacks Research raised their...
Corbus Pharmaceuticals’ (CRBP) Buy Rating Reiterated at HC Wainwright
HC Wainwright reaffirmed their buy rating on shares of Corbus Pharmaceuticals (NASDAQ:CRBP – Free Report)...
Oppenheimer Asset Management Inc. Decreases Position in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)
Oppenheimer Asset Management Inc. lowered its stake in shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL –...
Jazz Pharmaceuticals (NASDAQ:JAZZ) Sees Large Volume Increase After Analyst Upgrade
Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Get Free Report) saw unusually-high trading volume on Wednesday after...
BioCryst Pharmaceuticals (NASDAQ:BCRX) Now Covered by Wedbush
Wedbush initiated coverage on shares of BioCryst Pharmaceuticals (NASDAQ:BCRX – Get Free Report) in a...
State of New Jersey Common Pension Fund D Raises Stock Position in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)
State of New Jersey Common Pension Fund D raised its stake in shares of Ionis...
Allworth Financial LP Has $745,000 Stock Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Allworth Financial LP increased its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free...
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Given Average Recommendation of “Moderate Buy” by Analysts
Shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Get Free Report) have earned a consensus recommendation...
Christopher Peetz Sells 9,102 Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Stock
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Free Report) CEO Christopher Peetz sold 9,102 shares of...
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Sees Large Drop in Short Interest
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL – Get Free Report) was the target of a significant decrease...